🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/04/2018 | 56,62 | 56,92 | 56,59 | 56,75 | +0,10% | 0,57% | 8.034.073 |
| 26/04/2018 | 57,08 | 57,34 | 56,40 | 56,69 | -0,37% | 1,64% | 14.148.105 |
| 25/04/2018 | 57,16 | 57,18 | 56,23 | 56,90 | -0,77% | 1,65% | 14.057.034 |
| 24/04/2018 | 57,64 | 58,21 | 57,03 | 57,34 | -0,27% | 2,04% | 13.974.975 |
| 23/04/2018 | 57,30 | 57,84 | 56,71 | 57,49 | +2,41% | 1,98% | 20.767.587 |
| 20/04/2018 | 56,16 | 56,56 | 55,97 | 56,14 | +0,32% | 1,04% | 10.109.951 |
| 19/04/2018 | 56,22 | 56,60 | 55,74 | 55,95 | -0,48% | 1,53% | 11.041.204 |
| 18/04/2018 | 56,69 | 56,89 | 55,91 | 56,22 | -0,59% | 1,73% | 11.779.730 |
| 17/04/2018 | 57,10 | 57,21 | 56,26 | 56,56 | +1,06% | 1,67% | 16.070.451 |
| 16/04/2018 | 55,12 | 56,54 | 54,55 | 55,96 | +2,59% | 3,60% | 23.627.998 |
| 13/04/2018 | 54,47 | 54,70 | 54,05 | 54,55 | +0,76% | 1,21% | 10.536.278 |
| 12/04/2018 | 54,01 | 54,57 | 53,57 | 54,14 | +0,96% | 1,86% | 12.511.967 |
| 11/04/2018 | 53,49 | 53,95 | 53,33 | 53,63 | -0,51% | 1,16% | 9.445.834 |
| 10/04/2018 | 54,08 | 54,19 | 53,47 | 53,90 | +0,59% | 1,32% | 13.481.891 |
| 09/04/2018 | 52,48 | 54,79 | 52,06 | 53,59 | +5,25% | 5,20% | 24.352.376 |
| 06/04/2018 | 51,79 | 52,08 | 50,48 | 50,92 | -2,15% | 3,10% | 13.100.838 |
| 05/04/2018 | 52,54 | 52,84 | 51,95 | 52,03 | -0,02% | 1,71% | 13.074.638 |
| 04/04/2018 | 51,02 | 52,19 | 50,95 | 52,04 | +0,83% | 2,41% | 9.330.030 |
| 03/04/2018 | 50,90 | 51,67 | 50,41 | 51,61 | +1,54% | 2,47% | 9.688.341 |
| 02/04/2018 | 51,91 | 52,15 | 50,53 | 50,83 | -2,20% | 3,11% | 14.041.104 |
| 29/03/2018 | 52,82 | 52,87 | 51,98 | 51,98 | -1,13% | 1,70% | 10.218.524 |
| 28/03/2018 | 51,57 | 52,81 | 51,55 | 52,57 | +2,49% | 2,44% | 13.302.788 |
| 27/03/2018 | 51,52 | 52,06 | 51,02 | 51,29 | -0,54% | 2,02% | 16.956.535 |
| 26/03/2018 | 51,57 | 51,68 | 50,54 | 51,56 | +1,18% | 2,20% | 10.448.770 |
| 23/03/2018 | 51,83 | 52,20 | 50,90 | 50,96 | -1,31% | 2,52% | 12.408.634 |
| 22/03/2018 | 51,76 | 52,46 | 51,56 | 51,64 | -1,04% | 1,75% | 13.387.990 |
| 21/03/2018 | 52,25 | 52,75 | 51,93 | 52,19 | +0,09% | 1,57% | 10.489.746 |
| 20/03/2018 | 52,24 | 52,42 | 51,87 | 52,14 | +0,02% | 1,06% | 8.153.440 |
| 19/03/2018 | 53,11 | 53,13 | 51,76 | 52,13 | -1,87% | 2,59% | 12.391.762 |
| 16/03/2018 | 52,66 | 53,29 | 52,56 | 53,12 | +0,76% | 1,40% | 22.010.620 |